Details of the Drug

General Information of Drug (ID: DM914KY)

Drug Name

Human retinal pigment epithelial cell therapy

Indication

Disease Entry	ICD 11	Status	REF
Macular degeneration	9B78.3	Phase 1/2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet. 2015 Feb 7;385(9967):509-16.